US 10364295
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 10364295 (Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers) held by PRECISION BIOLOGICS, INC. expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECISION BIOLOGICS, INC.
- Grant date
- Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/39558, A61K45/06